2021 | Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population
| GUT |
2019 | Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma | Oncology |
2007 | Different criteria for HER2 positivity by IHC can be applied in post-chemotherapy specimens in determining HER2 as a prognosticator in locally advanced breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
1998 | Different expression patterns of MMP-2 and MMP-9 in breast cancer | ONCOLOGY REPORTS |
2005 | Different role of functional domains of hTR in DNA binding to telomere and telomerase reconstruction
| FEBS LETTERS |
2017 | Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia
| ANNALS OF SURGERY |
2024 | Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinoma | BIOORGANIC CHEMISTRY |
2008 | Disease Prediction Using Ranks of Gene Expressions
| Genomics & Informatics |
2011 | DNA methylation predicts recurrence from resected stage III proximal colon cancer
| CANCER |
2015 | Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?
| MEDICINE |
2009 | Docetaxel versus paclitaxel combined with 5-FU and leucovorin in advanced gastric cancer: combined analysis of two phase II trials.
| CANCER RESEARCH AND TREATMENT |
2015 | Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer
| AMERICAN JOURNAL OF CANCER RESEARCH |
2016 | Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples. | EXPERIMENTAL AND MOLECULAR PATHOLOGY |
2001 | Early Postoperative Intraperitoneal Chemotherapy with Mitomycin C, 5-Fluorouracil and Cisplatin for Advanced Gastric Cancer | ONCOLOGY |
2009 | Effect of being overweight on postoperative morbidity and long-term surgical outcomes in proximal gastric carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2019 | Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial | JAMA Network Open |
2017 | Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
1999 | Effects of interleukin-2 transduction on the human hepatoma cell lines using retroviral vector | ONCOLOGY REPORTS |
2010 | Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma | INTERNATIONAL JOURNAL OF HYPERTHERMIA |
2018 | Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical Trials | CLINICAL BREAST CANCER |
2022 | Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors
| NEURO-ONCOLOGY |
2020 | Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies | INTERNATIONAL JOURNAL OF CANCER |
2019 | Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study | JOURNAL OF CLINICAL ONCOLOGY |
2018 | Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: Pooled analyses after long-term follow-up in KEYNOTE-012 | BRITISH JOURNAL OF CANCER |
2023 | Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study | CANCER |
2020 | Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial | JAMA ONCOLOGY |
2020 | Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study | JOURNAL OF CLINICAL ONCOLOGY |
2021 | Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score ≥10
| CLINICAL CANCER RESEARCH |
2001 | Efficacy of Pre - and Postoperative Chemotherapy in Patients with Osteosarcoma of the Extremities
| CANCER RESEARCH AND TREATMENT |
2007 | Entropy-based analysis of the non-linear relationship between gene expression profiles of amplified and non-amplified RNA | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
2012 | Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group | JOURNAL OF CLINICAL ONCOLOGY |
2013 | Estimating the Adjuvant Chemotherapy Effect in Elderly Stage II and III Colon Cancer Patients in an Observational Study | JOURNAL OF SURGICAL ONCOLOGY |
2022 | Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study
| EUROPEAN JOURNAL OF CANCER |
2012 | Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: a multicenter, cross-sectional study | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
2013 | Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study | JOURNAL OF CLINICAL ONCOLOGY |
2022 | Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2021 | Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study | LANCET ONCOLOGY |
2022 | Exploratory analysis of the impact of prior immune checkpoint inhibitor (ICI) on trastuzumab deruxtecan (T-DXd; DS-8201) clinical outcomes and biomarkers (BM) in DESTINY-Gastric01 (DG-01), a randomized, phase 2, multicenter, open-label study in patients (pts) with HER2+ advanced gastric or gastroesophageal junction adenocarcinoma | JOURNAL OF CLINICAL ONCOLOGY |
2020 | Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer
| GASTRIC CANCER |
2009 | Expression of anaphase-promoting complex7 in fibroadenomas and phyllodes tumors of breast | HUMAN PATHOLOGY |
2004 | Fabrication of high quality cDNA microarray using a small amount of cDNA | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
2017 | Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer
| CLINICAL EPIGENETICS |
2024 | First-in-Human Phase 1 Study of a B Cell- and Monocyte-Based Immunotherapeutic Vaccine Against HER2-Positive Advanced Gastric Cancer
| CANCER RESEARCH AND TREATMENT |
2022 | First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer
| ANNALS OF ONCOLOGY |
2021 | First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811
| FUTURE ONCOLOGY |
2012 | FKBP5 polymorphisms as vulnerability to anxiety and depression in patients with advanced gastric cancer: a controlled and prospective study | PSYCHONEUROENDOCRINOLOGY |
2018 | Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor | INTERNATIONAL JOURNAL OF CANCER |
2009 | G-T haplotype (2677G>T/A and 3435C>T) of ABCB1 gene polymorphisms is associated with ethnic differences to paclitaxel sensitivity in cancer cells with different gene expression pattern | CANCER LETTERS |
1996 | Gastric Cancer in Young Patients Who Underwent Curative Resection: Comparative Study with Older Patients | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
2007 | Gastrointestinal stromal tumor of the rectum: An analysis of seven cases | SURGERY TODAY |
2005 | Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
2005 | Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients
| CLINICAL CANCER RESEARCH |
2020 | Gene Expression Profiling Identifies Akt as a Target for Radiosensitization in Gastric Cancer Cells
| FRONTIERS IN ONCOLOGY |
2016 | Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites
| ONCOTARGET |
2009 | Genetic and epigenetic marker-based DNA test of stool is a promising approach for colorectal cancer screening
| YONSEI MEDICAL JOURNAL |
2003 | Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray | INTERNATIONAL JOURNAL OF ONCOLOGY |
2007 | Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization
| BMC GENOMICS |
2013 | Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer | JOURNAL OF MOLECULAR DIAGNOSTICS |
2011 | Genome-wide molecular characterization of mucinous colorectal adenocarcinoma using cDNA microarray analysis. | ONCOLOGY REPORTS |
2022 | Genomic profiling as a response predictor of second-line treatment in advanced gastric cancer patients: Post-hoc analyses of two phase Ib/II trials | JOURNAL OF CLINICAL ONCOLOGY |